BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9639295)

  • 1. High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635.
    Le Bars D; Lemaire C; Ginovart N; Plenevaux A; Aerts J; Brihaye C; Hassoun W; Leviel V; Mekhsian P; Weissmann D; Pujol JF; Luxen A; Comar D
    Nucl Med Biol; 1998 May; 25(4):343-50. PubMed ID: 9639295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
    Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a [6-pyridinyl-18F]-labelled fluoro derivative of WAY-100635 as a candidate radioligand for brain 5-HT1A receptor imaging with PET.
    Karramkam M; Hinnen F; Berrehouma M; Hlavacek C; Vaufrey F; Halldin C; McCarron JA; Pike VW; Dollé F
    Bioorg Med Chem; 2003 Jul; 11(13):2769-82. PubMed ID: 12788351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of p-[(18)F]MPPF, a fluoro analog of WAY-100635 for visualization of 5-HT(1a) receptors.
    Ginovart N; Hassoun W; Le Bars D; Weissmann D; Leviel V
    Synapse; 2000 Mar; 35(3):192-200. PubMed ID: 10657026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.
    Shiue CY; Shiue GG; Mozley PD; Kung MP; Zhuang ZP; Kim HJ; Kung HF
    Synapse; 1997 Feb; 25(2):147-54. PubMed ID: 9021895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of fluorine-18-labeled 5-HT1A antagonists.
    Lang L; Jagoda E; Schmall B; Vuong BK; Adams HR; Nelson DL; Carson RE; Eckelman WC
    J Med Chem; 1999 May; 42(9):1576-86. PubMed ID: 10229627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.
    McCarron JA; Pike VW; Halldin C; Sandell J; Sóvágó J; Gulyas B; Cselényi Z; Wikström HV; Marchais-Oberwinkler S; Nowicki B; Dollé F; Farde L
    Mol Imaging Biol; 2004; 6(1):17-26. PubMed ID: 15018825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
    Defraiteur C; Lemaire C; Luxen A; Plenevaux A
    Nucl Med Biol; 2006 Jul; 33(5):667-75. PubMed ID: 16843842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.
    Passchier J; van Waarde A; Pieterman RM; Elsinga PH; Pruim J; Hendrikse HN; Willemsen AT; Vaalburg W
    J Nucl Med; 2000 Nov; 41(11):1830-5. PubMed ID: 11079490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis.
    Zimmer L; Mauger G; Le Bars D; Bonmarchand G; Luxen A; Pujol JF
    J Neurochem; 2002 Jan; 80(2):278-86. PubMed ID: 11902118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]fluoroalkyl analogues of the potent 5-HT1A antagonist WAY 100635: radiosyntheses and in vivo evaluation.
    Wilson AA; DaSilva JN; Houle S
    Nucl Med Biol; 1996 May; 23(4):487-90. PubMed ID: 8832704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.
    Plenevaux A; Weissmann D; Aerts J; Lemaire C; Brihaye C; Degueldre C; Le Bars D; Comar D; Pujol J; Luxen A
    J Neurochem; 2000 Aug; 75(2):803-11. PubMed ID: 10899958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
    Doll F; Dolci L; Valette H; Hinnen F; Vaufrey F; Guenther I; Fuseau C; Coulon C; Bottlaender M; Crouzel C
    J Med Chem; 1999 Jun; 42(12):2251-9. PubMed ID: 10377231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus.
    Zimmer L; Rbah L; Giacomelli F; Le Bars D; Renaud B
    J Nucl Med; 2003 Sep; 44(9):1495-501. PubMed ID: 12960198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of 5-HT(1A) receptors in human brain using p-MPPF kinetic modelling and PET.
    Sanabria-Bohórquez SM; Biver F; Damhaut P; Wikler D; Veraart C; Goldman S
    Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):76-81. PubMed ID: 11807610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
    McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
    Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.